Sleep and Breathing

, Volume 17, Issue 2, pp 667–672 | Cite as

CPAP interface: satisfaction and side effects

  • Adel Bachour
  • Pirjo Vitikainen
  • Paula Virkkula
  • Paula Maasilta
Original Article



This study aimed to evaluate the care receiver's satisfaction with the continuous positive airway pressure (CPAP) interfaces.


A questionnaire with visual analog scales was sent to all our CPAP patients (0 = absolutely unsatisfied, 100 = very satisfied). From the ResMed ResScan program, we obtained the CPAP daily use and air leak values.


We received 730 answers (70 % of participants); females comprised 22 %. A total of 391 patients had ResMed interfaces, 227 had Respironics, 87 had Fisher & Paykel (F&P), and 25 patients had other interfaces. Interfaces were nasal for 79 %, nasal pillows for 9 %, oronasal for 9 %, and unidentified for 3 % of cases. The mean ± SD satisfaction rate was 68 ± 25. No statistically significant differences were found regarding the type or brand of interface, previous interface experience, or the age or gender of the patient. Users of ResMed interfaces had significantly (p < 0.01) fewer cases of disturbing leaks than did users of Respironics or F&P interfaces (60 vs. 70 and 72 %, respectively). The ResMed Ultra Mirage interface had the fewest cases of disturbing leaks. Values for the measured median leaks were a mean of 5.9 ± 7.2 l/min, and those for the maximum leaks were 39.3 ± 22.2 l/min with no differences between brands. The users of F&P interfaces experienced significantly (p < 0.01) more comfort and used the CPAP device significantly (p < 0.007) more than did users of ResMed or Respironics interfaces (88 % of cases vs. 65 and 57 % and 6.2 ± 2.6 vs. 5.3 ± 2.8 or 5.8 ± 2.8 h/day, respectively).


The majority of patients consider the use of the CPAP interface disturbing even though the satisfaction rate is good with no differences between brands.


CPAP interface Satisfaction questionnaire Side effects CPAP daily use Air leaks 


  1. 1.
    Jenkinson C, Davies RJ, Mullins R, Stradling JR (1999) Comparison of therapeutic and sub-therapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized prospective parallel trial. Lancet 353:2100–2105PubMedCrossRefGoogle Scholar
  2. 2.
    Corda L, Redolfi S, Montemurro LT, La Piana GE, Bertella E, Tantucci C (2009) Short- and long-term effects of CPAP on upper airway anatomy and collapsibility in OSAH. Sleep Breath 13:187–193PubMedCrossRefGoogle Scholar
  3. 3.
    Kakkar RK, Berry RB (2007) Positive airway pressure treatment for obstructive sleep apnea. Chest 132:1057–1072PubMedCrossRefGoogle Scholar
  4. 4.
    Pepin JL, Leger P, Veale D, Langevin B, Robert D, Lévy P (1995) Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest 107:375–381PubMedCrossRefGoogle Scholar
  5. 5.
    Sin DD, Mayers I, Man GC, Pawluk L (2002) Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 121:430–435PubMedCrossRefGoogle Scholar
  6. 6.
    Bachour A, Maasilta P (2004) Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest 126:1248–1254PubMedCrossRefGoogle Scholar
  7. 7.
    Valentin A, Subramanian S, Quan SF, Berry RB, Parthasarathy S (2011) Air leak is associated with poor adherence to autoPAP therapy. Sleep 34:801–806PubMedGoogle Scholar
  8. 8.
    Weaver TE, Grunstein RR (2008) Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 5:173–178PubMedCrossRefGoogle Scholar
  9. 9.
    Berry RB (2000) Improving CPAP compliance—man more than machine. Sleep Med 1:175–178PubMedCrossRefGoogle Scholar
  10. 10.
    Ryan S, Garvey JF, Swan V, Behan R, McNicholas WT (2011) Nasal pillows as an alternative interface in patients with obstructive sleep apnoea syndrome initiating continuous positive airway pressure therapy. J Sleep Res 20:367–373PubMedCrossRefGoogle Scholar
  11. 11.
    Chai CL, Pathinathan A, Smith BJ (2006) Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database of Systematic Reviews Issue 4. Art. no.: CD005308Google Scholar
  12. 12.
    Bachour A, Virkkala J, Maasilta P (2007) AutoCPAP initiation at home: optimal trial duration and cost-effectiveness. Sleep Med 8:704–710PubMedCrossRefGoogle Scholar
  13. 13.
    Hinchey SA, Jackson J (2011) A cohort study assessing difficult patient encounters in a walk-in primary care clinic; predictors and outcomes. J Gen Intern Med 26:588–594PubMedCrossRefGoogle Scholar
  14. 14.
    Mika K, Riitta A, Markku P, Tiina L, Barengo Noel C, Antti J, Veikko S, Pekka J, Aulikki N, Erkki V, Jaakko T (2009) Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens 27:1552–1559CrossRefGoogle Scholar
  15. 15.
    Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147:887–895PubMedCrossRefGoogle Scholar
  16. 16.
    McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:1108–1114PubMedCrossRefGoogle Scholar
  17. 17.
    Mulgrew AT, Cheema R, Fleetham J, Ryan CF, Ayas NT (2007) Efficacy and patient satisfaction with autoadjusting CPAP with variable expiratory pressure vs standard CPAP: a two-night randomized crossover trial. Sleep Breath 11:31–37PubMedCrossRefGoogle Scholar
  18. 18.
    Teo M, Amis T, Lee S, Falland K, Lambert S, Wheatley J (2011) Equivalence of nasal and oronasal masks during initial CPAP titration for obstructive sleep apnea syndrome. Sleep 34:951–955PubMedGoogle Scholar
  19. 19.
    Massie CA, Hart RW (2003) Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure. Chest 123:1112–1118PubMedCrossRefGoogle Scholar
  20. 20.
    Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Mao-Chang Su, Lam J, Douglas Bradley T (2009) Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 179:241–246PubMedCrossRefGoogle Scholar
  21. 21.
    Tang SC, Lam B, Lam JC, Chan CK, Chow CC, Ho YW, Ip MS, Lai KN (2012) Impact of nephrotic edema of the lower limbs on obstructive sleep apnea: gathering a unifying concept for the pathogenetic role of nocturnal rostral fluid shift. Nephrol Dial Transplant 0:1–6Google Scholar
  22. 22.
    Wimms AJ, Richards GN, Benjafield AV (2012) Assessment of the impact on compliance of a new CPAP system in obstructive sleep apnea. Sleep Breath. doi:10.1007/s11325-012-0651-0
  23. 23.
    Virkkula P, Rinne J, Bachour A (2008) Kuorsaajan nenä. Duodecim 124:641–648Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Adel Bachour
    • 1
  • Pirjo Vitikainen
    • 1
  • Paula Virkkula
    • 2
  • Paula Maasilta
    • 1
  1. 1.Sleep Unit, Pulmonary DepartmentHelsinki University HospitalHelsinkiFinland
  2. 2.Department of ENTHelsinki University HospitalHelsinkiFinland

Personalised recommendations